Clinical Trial Update: A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 study of intravitreal AVD-104 in diabetic macular edema terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• AVD-104

Snippet

Sponsor: Aviceda Therapeutics, Inc. | Conditions: Diabetic Macular Edema, Diabetic Retinopathy | Phase 2 | Status: TERMINATED | Results posted: 2025-07-14